Literature DB >> 25976560

Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.

Chenghu Huang1, Li Yuan1, Shuyi Cao1.   

Abstract

The number of pro-α cells is known to increase in response to β cell injury and these cells then generate glucagon-like peptide-1 (GLP-1), thus attenuating the development of diabetes. The aim of the present study was to further examine the role and the mechanisms responsible for intra-islet GLP-1 production as a self-protective response against lipotoxicity. The levels of the key enzyme, prohormone convertase 1/3 (PC1/3), as well as the synthesis and release of GLP-1 in models of lipotoxicity were measured. Furthermore, islet viability, apoptosis, oxidative stress and inflammation, as well as islet structure were assessed after altering GLP-1 receptor signaling. Both prolonged exposure to palmitate and a high-fat diet facilitated PC1/3 expression, as well as the synthesis and release of GLP-1 induced by β cell injury and the generation of pro-α cells. Prolonged exposure to palmitate increased reactive oxygen species (ROS) production, and the antioxidant, N-acetylcysteine (NAC), partially prevented the detrimental effects induced by palmitate on β cells, resulting in decreased GLP-1 levels. Furthermore, the inhibition of GLP-1 receptor (GLP-1R) signaling by treatment with exendin‑(9-39) further decreased cell viability, increased cell apoptosis and caused a stronger inhibition of the β cell-specific transcription factor, pancreatic duodenal homeobox 1 (PDX1). Moreover, treatment with the GLP-1R agonist, liraglutide, normalized islet structure and function, resulting in a decrease in cell death and in the amelioration of β cell marker expression. Importantly, liraglutide maintained the oxidative balance and decreased inflammatory factor and p65 expression. Overall, our data demonstrate that an increase in the number of pro-α cells and the activation of the intra-islet GLP-1 system comprise a self-defense mechanism for enhancing β cell survival to combat lipid overload, which is in part mediated by oxidative stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25976560      PMCID: PMC4494597          DOI: 10.3892/ijmm.2015.2207

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  43 in total

1.  Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival.

Authors:  Z Liu; V Stanojevic; S Avadhani; T Yano; J F Habener
Journal:  Diabetologia       Date:  2011-05-13       Impact factor: 10.122

2.  Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats.

Authors:  Y Nie; M Nakashima; P L Brubaker; Q L Li; R Perfetti; E Jansen; Y Zambre; D Pipeleers; T C Friedman
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 3.  Lipotoxicity, fatty acid uncoupling and mitochondrial carrier function.

Authors:  Eduardo Rial; Leonor Rodríguez-Sánchez; Eunate Gallardo-Vara; Pilar Zaragoza; Eva Moyano; M Mar González-Barroso
Journal:  Biochim Biophys Acta       Date:  2010-04-11

Review 4.  Role of pancreatic β-cell death and inflammation in diabetes.

Authors:  W Quan; E-K Jo; M-S Lee
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 5.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

6.  A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.

Authors:  Julio C Fraulob; Rebeca Ogg-Diamantino; Caroline Fernandes-Santos; Marcia Barbosa Aguila; Carlos A Mandarim-de-Lacerda
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

7.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

8.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Authors:  T J Kieffer; C H McIntosh; R A Pederson
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

9.  Glucolipotoxicity in Pancreatic β-Cells.

Authors:  Ji-Won Kim; Kun-Ho Yoon
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

10.  Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin.

Authors:  Yanqing Zhang; Yuan Zhang; Robert N Bone; Wanxing Cui; Ji-Bin Peng; Gene P Siegal; Hongjun Wang; Hongju Wu
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more
  11 in total

Review 1.  Intra-islet glucagon-like peptide 1.

Authors:  Genevieve E Fava; Emily W Dong; Hongju Wu
Journal:  J Diabetes Complications       Date:  2016-05-20       Impact factor: 2.852

2.  Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.

Authors:  Tao Tao; Yi Zhang; Yu-Chen Zhu; Jia-Rong Fu; Yu-Ying Wang; Jie Cai; Jing-Yu Ma; Yu Xu; Yi-Ning Gao; Yun Sun; WuQiang Fan; Wei Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

3.  Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome.

Authors:  Maarja Toots; Kadri Seppa; Toomas Jagomäe; Tuuliki Koppel; Maia Pallase; Indrek Heinla; Anton Terasmaa; Mario Plaas; Eero Vasar
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

4.  Berberine Reshapes the Balance of the Local Renin-Angiotensin System by Modulating Autophagy under Metabolic Stress in Pancreatic Islets.

Authors:  Chenghu Huang; Pan Lei; Caibi Peng; Min Li; Yifei Guo; Xuefeng Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-08-03       Impact factor: 1.636

5.  The Impact of Incretin-Based Medications on Lipid Metabolism.

Authors:  Habib Yaribeygi; Mina Maleki; Alexandra E Butler; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2021-12-29       Impact factor: 4.011

Review 6.  Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion.

Authors:  Marlena M Holter; Mridusmita Saikia; Bethany P Cummings
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

Review 7.  Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.

Authors:  Safia Costes; Gyslaine Bertrand; Magalie A Ravier
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 8.  Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.

Authors:  Young-Sun Lee; Hee-Sook Jun
Journal:  Mediators Inflamm       Date:  2016-03-24       Impact factor: 4.711

Review 9.  Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.

Authors:  Alina Kuryłowicz; Krzysztof Koźniewski
Journal:  Molecules       Date:  2020-05-09       Impact factor: 4.411

10.  GLP-2 Is Locally Produced From Human Islets and Balances Inflammation Through an Inter-Islet-Immune Cell Crosstalk.

Authors:  Wei He; Osmond D Rebello; Antonia Henne; Fabian Nikolka; Thomas Klein; Kathrin Maedler
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.